A16. INTERROGATING GENOMIC, TRANSCRIPTIONAL, AND EPIGENETIC MECHANISMS IN LUNG FIBROSIS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1036-A1036
B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2840-A2840
B94. DISEASE PROGRESSION AND MORBIDITY ALONG THE SPECTRUM OF COPD: FROM EARLY TO ESTABLISHED | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4203-A4203
C67. COPD: TRANSLATIONAL SCIENCE | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4678-A4678
B101. VARIED OMICS TECHNIQUES APPLIED TO ALLERGIC AND RESPIRATORY TRAITS | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A3489-A3489
A22. IMAGING AND MOLECULAR BIOMARKERS IN COPD | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A1080-A1080
TP26. TP026 DIAGNOSIS, ASSESSMENT, AND PROGNOSIS OF FIBROTIC ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1839-A1839